William L. Ince

3.0k total citations · 1 hit paper
19 papers, 2.3k citations indexed

About

William L. Ince is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, William L. Ince has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in William L. Ince's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (7 papers) and Immune Cell Function and Interaction (4 papers). William L. Ince is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (7 papers) and Immune Cell Function and Interaction (4 papers). William L. Ince collaborates with scholars based in United States, Slovakia and France. William L. Ince's co-authors include Kenneth J. Hillan, Jonathan W. Yewdell, Jack R. Bennink, David A. Ramies, Bruce E. Johnson, Vincent A. Miller, Sherry Heldens, Thomas Januario, Lukas C. Amler and Jeremy Stinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

William L. Ince

19 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

2005 1.2k citations David A. Eberhard, Bruce E. Johnson et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by William L. Ince

Since Specialization

Citations

This map shows the geographic impact of William L. Ince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Ince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Ince more than expected).

Fields of papers citing papers by William L. Ince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Ince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Ince. The network helps show where William L. Ince may publish in the future.

Co-authorship network of co-authors of William L. Ince

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Ince. A scholar is included among the top collaborators of William L. Ince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Ince. William L. Ince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility 2023 ·Journal of Virology ·Brady T. Hickerson, (unknown), Harold Dickensheets, Raymond P. Donnelly, William L. Ince, Natalia A. Ilyushina	15
2	Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression 2022 ·Antimicrobial Agents and Chemotherapy ·Brady T. Hickerson, Simone E. Adams, Subrata Barman, Lance A. Miller, Vladimir Y. Lugovtsev, Richard J. Webby, William L. Ince, Raymond P. Donnelly, Natalia A. Ilyushina	11
3	Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil 2020 ·The Journal of Infectious Diseases ·William L. Ince, Fraser Smith, Julian J. O’Rear, Michael M. Thomson	34
4	Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies 2019 ·Virology Journal ·Natalia A. Ilyushina, Takashi Komatsu, William L. Ince, Eric Donaldson, (unknown), Julian J. O’Rear, Raymond P. Donnelly	19
5	Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference 2019 ·Antiviral Research ·John H. Beigel, Hannah Nam, (unknown), Amy E. Krafft, William L. Ince, Samer S. El‐Kamary, Amy Sims	124
6	Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs 2018 ·PLoS Pathogens ·Ivan Košík, William L. Ince, Lauren E. Gentles, Andrew J. Oler, Martina Košíková, Matthew Angel, Javier G. Magadán, Hang Xie, Christopher B. Brooke, Jonathan W. Yewdell	56
7	A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus 2015 ·mBio ·Gregory M. Frank, Davide Angeletti, William L. Ince, James S. Gibbs, Surender Khurana, Adam K. Wheatley, Edward E. Max, Adrian B. McDermott, Hana Golding, James Stevens, Jack R. Bennink, Jonathan W. Yewdell	34
8	Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes 2014 ·PLoS Pathogens ·Javier G. Magadán, Meghan O. Altman, William L. Ince, Heather D. Hickman, James Stevens, Aaron Chevalier, David Baker, Patrick C. Wilson, Rafi Ahmed, Jack R. Bennink, Jonathan W. Yewdell	9
9	Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility 2014 ·Proceedings of the National Academy of Sciences ·Christopher B. Brooke, William L. Ince, Jiajie Wei, Jack R. Bennink, Jonathan W. Yewdell	52
10	Most Influenza A Virions Fail To Express at Least One Essential Viral Protein 2013 ·Journal of Virology ·Christopher B. Brooke, William L. Ince, Jens Wrammert, Rafi Ahmed, Patrick C. Wilson, Jack R. Bennink, Jonathan W. Yewdell	127
11	Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection 2013 ·Cell Host & Microbe ·Suman R. Das, Scott E. Hensley, William L. Ince, Christopher B. Brooke, (unknown), Mark G. Delboy, Gustáv Russ, James S. Gibbs, Jack R. Bennink, Jonathan W. Yewdell	86
12	Most Influenza A Virions Fail To Express at Least One Essential Viral Protein 2013 ·Journal of Virology ·Christopher B. Brooke, William L. Ince, Jens Wrammert, Rafi Ahmed, Patrick C. Wilson, Jack R. Bennink, Jonathan W. Yewdell	2
13	Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 Genes To Accelerate Adaptation to a New Host 2013 ·Journal of Virology ·William L. Ince, (unknown), Jack R. Bennink, Jonathan W. Yewdell	52
14	Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy 2011 ·Proceedings of the National Academy of Sciences ·Suman R. Das, Scott E. Hensley, Alexandre David, (unknown), James S. Gibbs, Pere Puigbò, William L. Ince, Jack R. Bennink, Jonathan W. Yewdell	110
15	Evolution of the HIV-1 env Gene in the Rag2 ^−/− γ _C ^−/− Humanized Mouse Model 2009 ·Journal of Virology ·William L. Ince, Liguo Zhang, Qi Jiang, Kathryn T. Arrildt, Lishan Su, Ronald Swanstrom	33
16	Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4 ⁺ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2 ^−/− γ _c ^−/− Mouse 2009 ·Journal of Virology ·Shailesh K. Choudhary, Naser L. Rezk, William L. Ince, Manzoor Cheema, Liguo Zhang, Lishan Su, Ronald Swanstrom, Angela D. M. Kashuba, David M. Margolis	64
17	Major Coexisting Human Immunodeficiency Virus Type 1envGene Subpopulations in the Peripheral Blood Are Produced by Cells with Similar Turnover Rates and Show Little Evidence of Genetic Compartmentalization 2009 ·Journal of Virology ·William L. Ince, Patrick R. Harrington, Gretja Schnell, (unknown), Christina L. Burch, Prema Menezes, Richard W. Price, Joseph J. Eron, Ronald Swanstrom	13
18	Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab 2005 ·JNCI Journal of the National Cancer Institute ·William L. Ince, Adrian M. Jubb, Scott N. Holden, Eric Holmgren, (unknown), (unknown), Herbert I. Hurwitz, Fairooz F. Kabbinavar, William Novotny, Kenneth J. Hillan, Hartmut Koeppen	262
19	Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib breakdown → 2005 ·Journal of Clinical Oncology ·David A. Eberhard, Bruce E. Johnson, Lukas C. Amler, Audrey D. Goddard, Sherry Heldens, Roy S. Herbst, William L. Ince, Pasi A. Jänne, Thomas Januario, David H. Johnson, Pam Klein, Vincent A. Miller, (unknown), David A. Ramies, Dragan Sebisanovic, Jeremy Stinson, (unknown), Somasekar Seshagiri, Kenneth J. Hillan	1200

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact